COMMUNIQUÉS West-GlobeNewswire

Clearside Biomedical to Report Second Quarter 2018 Financial Results on August 8, 2018 – Conference Call to Follow
01/08/2018
ALPHARETTA, Ga., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
MPX Receives Final Licensing Approval for Two Managed Dispensaries in Maryland
01/08/2018
TORONTO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) is pleased to announce the Company, through its indirect wholly-owned subsidiary, S8 Management [...]
KemPharm to Present at Canaccord Genuity 38th Annual Growth Conference
01/08/2018
CORALVILLE, Iowa, Aug. 01, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that its president [...]
Intellia Therapeutics Announces Second Quarter 2018 Financial Results
01/08/2018
Continued to progress lead in vivo program in transthyretin amyloidosis targeting submission of an Investigational New Drug application by the end of 2019 Announced first wholly owned ex vivo T cell receptor program [...]
Neos Therapeutics to Host Second Quarter 2018 Financial Results Conference Call on August 8, 2018
01/08/2018
DALLAS and FORT WORTH, Texas, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]
Myriad to Announce Fiscal Fourth-Quarter 2018 Financial Results on August 14, 2018
01/08/2018
SALT LAKE CITY, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will hold its fiscal fourth-quarter 2018 sales [...]
EyePoint Pharmaceuticals Appoints David Price as Chief Financial Officer
01/08/2018
Seasoned financial executive brings more than 25 years of diverse financial and operational experience WATERTOWN, Mass., Aug. 01, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty [...]
ProQR Announces Publication on QR-110 for Leber’s Congenital Amaurosis 10 in the Journal Molecular Therapy - Nucleic Acids
01/08/2018
LEIDEN, the Netherlands, Aug. 01, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe [...]
Cerecor Announces First Patient Enrolled in Phase I Trial for Neurogenic Orthostatic Hypotension (nOH) in Parkinson’s Disease
01/08/2018
Study to evaluate safety, tolerability and effects on blood pressure of CERC-301 in patients with nOH BALTIMORE, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), today announced that it has enrolled [...]
Emblem Corp. and GreenSpace Brands partner to launch new CBD-infused health and beauty line
01/08/2018
Partnership focused on long-term brand building and national distribution of CBD-infused health and beauty products TORONTO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCBB:EMMBF) (“Emblem”) and [...]
PotNetwork Holdings Books Over 400 New Orders at the 2018 Premiere Trade Show, ASD Market Week, July 29-August 1
01/08/2018
Diamond CBD Sales Surge from Presentation of its Growing Product Line at Leading Industry Trade Show in Las Vegas FT LAUDERDALE, Fla., Aug. 01, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holdings, Inc. (OTC [...]
G1 Therapeutics to Provide Second Quarter 2018 Corporate and Financial Update on August 8, 2018
01/08/2018
RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced that it will host a webcast and conference call to provide a [...]
Edge Therapeutics Reports Second Quarter 2018 Financial Results
01/08/2018
BERKELEY HEIGHTS, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE) today announced financial results for the quarter ended June 30, 2018. Second Quarter Financial Results Cash Position: Cash [...]
Shire plc : Total voting rights
01/08/2018
Total Voting Rights August 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies [...]
Amarin Reports Second Quarter 2018 Financial Results and Provides Update on Operations
01/08/2018
REDUCE-IT™ Study On-Track for Reporting Top-Line Results by the End of September 2018 Management to Host Conference Call at 7:30 a.m. ET Today BEDMINSTER, N.J., and DUBLIN, Ireland, Aug. 01, 2018 (GLOBE NEWSWIRE) -- [...]
Shire plc : Half-year Report
01/08/2018
Half-yearly Report August 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG), ("Shire" / the "Company"/ the "Group") in accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, is [...]
Shire plc : Rule 2.9 Announcement
01/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 1 August 2018 [...]
Verona Pharma Initiates Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment
01/08/2018
This three-way crossover study will inform design of pivotal Phase 3 trials Top line data expected first quarter 2019 LONDON, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma [...]
Kiadis Pharma secures €20 million debt financing facility from Kreos Capital
01/08/2018
Kiadis Pharma secures €20 million debt financing facility from Kreos Capital Amsterdam, The Netherlands, August 1, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a [...]

Pages